Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken.
Watch this short video to learn why!

DEA Proposed Rule: Quota Management for Ephedrine, Pseudoephedrine, and Phenylpropanolamine

$129.99

Stay ahead of critical regulatory changes with this in-depth course on the DEA’s proposed revisions to quota management for schedule I and II controlled substances, including ephedrine, pseudoephedrine, and phenylpropanolamine. Learn about new quota subcategories, revised application procedures, and the expanded role of stakeholder input in shaping the final regulation. Get practical knowledge to ensure compliance, prevent diversion, and understand the supply chain visibility requirements affecting manufacturers and importers.

In this course you will learn the following:
* Understand the goals and intent behind the proposed rule.
* Identify the key regulatory changes and their implications.
* Recognize the process for public participation and comment submission.
* Describe the structure and subcategories of manufacturing and procurement quotas.
* Assess the potential impact of the proposed rule on affected entities.
* Appreciate the evolving nature of the rule based on stakeholder input.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.

Why This Course is Important
Without this course, you risk being unprepared for significant regulatory changes that impact quota applications, supply chain transparency, and compliance with federal controlled substance regulations.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Revision of Applications for Manufacturing and Procurement Quotas.

Key regulatory references include:

Course SKU
FR-26-1934-1

About Benchmarks:

Are you ready for this regulation? Use this benchmark to find out.

Each benchmark is build directly for the federal regulation.  They reflect the learning objectives of the related course.

The benchmark is not a “trivia test” – they help you evaluate your readiness to apply the new regulation.

Contact us for more information and/or personalized benchmarks for your specific organization/industry.

DEA Proposed Rule: Quota Management for Ephedrine, Pseudoephedrine, and Phenylpropanolamine

Stay ahead of critical regulatory changes with this in-depth course on the DEA’s proposed revisions to quota management for schedule I and II controlled substances, including ephedrine, pseudoephedrine, and phenylpropanolamine. Learn about new quota subcategories, revised application procedures, and the expanded role of stakeholder input in shaping the final regulation. Get practical knowledge to ensure compliance, prevent diversion, and understand the supply chain visibility requirements affecting manufacturers and importers.

In this course you will learn the following:
* Understand the goals and intent behind the proposed rule.
* Identify the key regulatory changes and their implications.
* Recognize the process for public participation and comment submission.
* Describe the structure and subcategories of manufacturing and procurement quotas.
* Assess the potential impact of the proposed rule on affected entities.
* Appreciate the evolving nature of the rule based on stakeholder input.

NOTE: Unless otherwise indicated, all Benchmarks are free of charge!

Why This Course is Important
Without this course, you risk being unprepared for significant regulatory changes that impact quota applications, supply chain transparency, and compliance with federal controlled substance regulations.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Revision of Applications for Manufacturing and Procurement Quotas.

Key regulatory references include:

Course SKU
FR-26-1934-1

Replenish your Studio Course Advisor Unit balance here . Please contact frsales@courseavenue.com if you need to purchase more. Talk to use about an Enterprise License to see if that is right for you!

DEA Proposed Rule: Quota Management for Ephedrine, Pseudoephedrine, and Phenylpropanolamine

$129.99

Why This Course is Important
Without this course, you risk being unprepared for significant regulatory changes that impact quota applications, supply chain transparency, and compliance with federal controlled substance regulations.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Revision of Applications for Manufacturing and Procurement Quotas.

Key regulatory references include:

Course SKU
FR-26-1934-1

Stay ahead of critical regulatory changes with this in-depth course on the DEA’s proposed revisions to quota management for schedule I and II controlled substances, including ephedrine, pseudoephedrine, and phenylpropanolamine. Learn about new quota subcategories, revised application procedures, and the expanded role of stakeholder input in shaping the final regulation. Get practical knowledge to ensure compliance, prevent diversion, and understand the supply chain visibility requirements affecting manufacturers and importers.

In this course you will learn the following:
* Understand the goals and intent behind the proposed rule.
* Identify the key regulatory changes and their implications.
* Recognize the process for public participation and comment submission.
* Describe the structure and subcategories of manufacturing and procurement quotas.
* Assess the potential impact of the proposed rule on affected entities.
* Appreciate the evolving nature of the rule based on stakeholder input.

Related products